Stock Events

Stock Events

MindWalk 

$1.4600
91
+$0.02+1.39% Thursday 20:00
-$0.03-1.88%Thursday 23:48After hours

Statistics

Day High
1.455
Day Low
1.445
52W High
3.25
52W Low
0.99
Volume
9,359
Avg. Volume
-
Mkt Cap
68.2M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q2 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.06
-0.06
-0.05
-0.04
Expected EPS
-0.05319111
Actual EPS
N/A

Financials

-121.96%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
35.28MRevenue
-43.03MNet Income

Analyst Ratings

5.00Average Price Target
The highest estimate is 5.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HYFT. It's not an investment recommendation.
Nebius Group N.V.
4
NBIS
Microsoft
3
MSFT
Tesla
3
TSLA
NVIDIA
3
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals is a leading biotech company that competes in the development of monoclonal antibodies, a core area of ImmunoPrecise Antibodies' business.
Adaptive Biotechnologies
ADPT
Mkt Cap3.39B
Adaptive Biotechnologies focuses on the immune-driven discovery and development of antibodies, directly competing with IPA's antibody discovery services.
AbCellera Biologics
ABCL
Mkt Cap2.48B
AbCellera Biologics uses a technology platform for antibody discovery that rivals ImmunoPrecise Antibodies' technologies and services.
Moderna
MRNA
Mkt Cap31.65B
Moderna, known for its mRNA technology, is expanding into antibody discovery and therapeutics, positioning it as a competitor in the biotech space.
Novavax
NVAX
Mkt Cap1.6B
Novavax, primarily focused on vaccine development, competes with IPA in the broader immunotherapy and antibody development market.
BioNTech
BNTX
Mkt Cap24.67B
BioNTech SE, while known for its COVID-19 vaccine, also engages in antibody research and development, making it a competitor.
Lilly(Eli) &
LLY
Mkt Cap1.08T
Eli Lilly and Company has a strong portfolio in antibody therapeutics, directly competing with IPA in the pharmaceutical and biotech market.
AMGEN
AMGN
Mkt Cap201.93B
Amgen is a biopharmaceutical company with a focus on human therapeutics, including antibodies, competing in similar therapeutic areas as IPA.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences is involved in the discovery, development, and commercialization of therapeutics, including antibodies, in areas that overlap with IPA's interests.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a global pharmaceutical company with a broad range of therapeutic products, including antibodies, competing across several of the same domains as ImmunoPrecise Antibodies.

About

MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Show more...
CEO
Dr. Jennifer Lynne Bath Ph.D.
Employees
102
Country
Canada
ISIN
CA6026871054

Listings

XNAS
US
HYFT
F
DE
TQB0.F
STU
DE
TQB0.STU
MU
DE
TQB0.MU

0 Comments

Share your thoughts

FAQ

What is MindWalk stock price today?▼
The current price of HYFT is $1.46 USD — it has increased by +1.39% in the past 24 hours. Watch MindWalk stock price performance more closely on the chart.
What is MindWalk stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange MindWalk stocks are traded under the ticker HYFT.
What is MindWalk market cap?▼
Today MindWalk has the market capitalization of 68.2M
When is the next MindWalk earnings date?▼
MindWalk is going to release the next earnings report on July 23, 2026.
What were MindWalk earnings last quarter?▼
HYFT earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.04 USD resulting in a -48.01% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is MindWalk revenue for the last year?▼
MindWalk revenue for the last year amounts to 35.28M USD.
What is MindWalk net income for the last year?▼
HYFT net income for the last year is -43.03M USD.
How many employees does MindWalk have?▼
As of July 10, 2026, the company has 102 employees.
In which sector is MindWalk located?▼
MindWalk operates in the Technology sector.
When did MindWalk complete a stock split?▼
MindWalk has not had any recent stock splits.
Where is MindWalk headquartered?▼
MindWalk is headquartered in Austin, Canada.